1.
Robert Chen, Paul Frankel, Leslie Popplewell, Tanya Siddiqi, Nora Ruel, Arnold Rotter, Sandra H. Thomas, Michelle Mott, Nitya Nathwani, Myo Htut, Auayporn Nademanee, Stephen J. Forman, Mark Kirschbaum. A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma. haematol [Internet]. 2015Mar.1 [cited 2022May18];100(3):357-62. Available from: https://haematologica.org/article/view/7307